Insider Trades of GLAXOSMITHKLINE PLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▲ Type Tran OwnerType Shares Traded Last Price Shares Held
THERAVANCE INC Beneficial Owner (10%) 11/02/2012 Form 4 Buy indirect 280,348 22.35 26,411,103
THERAVANCE INC Beneficial Owner (10%) 02/15/2013 Form 4 Buy indirect 116,527 22.03 26,527,630
THERAVANCE INC Beneficial Owner (10%) 04/30/2013 Form 4 Buy indirect 193,563 34.61 26,721,193
ONCOMED PHARMACEUTICALS INC Beneficial Owner (10%) 07/23/2013 Form 4 Acquisition (Non Open Market) indirect 2,607,546 0 2,607,546
THERAVANCE INC Beneficial Owner (10%) 07/30/2013 Form 4 Buy indirect 3,064,407 36.5 29,785,600
THERAVANCE INC Beneficial Owner (10%) 10/29/2013 Form 4 Buy indirect 130,473 37.66 29,916,073
AMICUS THERAPEUTICS INC Beneficial Owner (10%) 11/20/2013 Form 4 Buy indirect 1,500,000 2 11,315,825
GENOCEA BIOSCIENCES, INC. Other 02/10/2014 Form 4 Buy indirect 143,773 12 143,773
GENOCEA BIOSCIENCES, INC. Other 02/10/2014 Form 4 Acquisition (Non Open Market) indirect 1,527,894 0 1,671,667
THERAVANCE INC Beneficial Owner (10%) 02/11/2014 Form 4 Buy indirect 342,229 37.55 30,258,302
CONCERT PHARMACEUTICALS, INC. Other 02/19/2014 Form 4 Acquisition (Non Open Market) indirect 1,321,533 0 1,321,533
CONCERT PHARMACEUTICALS, INC. Other 02/19/2014 Form 4 Buy indirect 35,000 14 2,678,066
APPLIED GENETIC TECHNOLOGIES CORP Beneficial Owner (10%) 04/01/2014 Form 4 Acquisition (Non Open Market) indirect 1,885,836 0 1,885,836
APPLIED GENETIC TECHNOLOGIES CORP Beneficial Owner (10%) 04/01/2014 Form 4 Buy indirect 103,762 12 1,989,598
THERAVANCE INC Beneficial Owner (10%) 05/09/2014 Form 4 Buy indirect 317,770 26.89 30,576,072
THERAVANCE BIOPHARMA, INC. Beneficial Owner (10%) 06/02/2014 Form 4 Disposition (Non Open Market) indirect 436,802 0 8,299,218
THERAVANCE INC Beneficial Owner (10%) 08/11/2014 Form 4 Buy indirect 172,651 22.66 30,748,723